13D·WATCH Activist + Insider Intelligence Live feed Blog About Pilot
SCHEDULE Filed 2025-02-28 Event 2025-02-26 SEC 0000950170-25-030291 →

QVT Financial LP Allot Ltd. ALLT

Stake: 9.05% Shares: 3,555,793 CUSIP: M0854Q105 Class: Ordinary Shares, par value ILS 0.10 per share

Item 4 — Purpose of Transaction

The Reporting Persons expect to review on a continuing basis their investment in the Ordinary Shares and the Issuer's business, affairs, operations, financial position, capital needs, governance, management, strategy and future plans. As part of their review, they may from time to time engage in discussions or otherwise communicate about such matters with others, including, without limitation, members of the Board, management or representatives of the Issuer, other shareholders of the Issuer and other relevant parties. Based on such review and any such communications, as well as general economic, market and industry conditions and prospects existing at the time, the Reporting Persons may, subject to any then existing legal or contractual limitations: (a) purchase additional shares of Ordinary Shares, warrants, options or related derivatives in the open market, in privately negotiated transactions or otherwise; (b) sell all or a portion of the Shares of Ordinary Shares, warrants, options or related derivatives now beneficially owned or hereafter acquired by them; (c) enter into and/or dispose of certain derivative transactions with one or more counterparties and/or (d) to the extent permitted by applicable laws, borrow securities, including the Ordinary Shares, for the purpose of effecting, and effect, short sale transactions, and purchase securities for the purpose of closing out short positions in such securities. In addition, the Reporting Persons may evaluate, discuss and/or take action with respect to plans or proposals that could relate to or would result in: (a) the acquisition by any person of additional securities of the Issuer, or the disposition of securities of the Issuer; (b) an extraordinary corporate transaction, such as a merger, reorganization or liquidation, involving the Issuer or any of its subsidiaries; (c) a sale or transfer of a material amount of assets of the Issuer or any of its subsidiaries; (d) any change in the present Board or management of the Issuer, including any plans or proposals to change the number or term of directors or to fill any existing vacancies on the Board; (e) any material change in the present capitalization or dividend policy of the Issuer; (f) any other material change in the Issuer's business or corporate structure; (g) changes in the Issuer's charter, by-laws or instruments corresponding thereto or other actions which may impede the acquisition of control of the Issuer by any person; (h) causing a class of securities of the Issuer to be delisted from a national securities exchange or to cease to be authorized to be quoted in an inter-dealer quotation system of a registered national securities association; (i) a class of equity securities of the Issuer becoming eligible for termination of registration pursuant to Section 12(g)(4) of the Exchange Act; or (j) any action similar to any of those enumerated above. The Reporting Persons may, at any time, review or reconsider their position with respect to the Issuer and formulate plans or proposals with respect to any of such matters, but have no present intention of doing so. The Reporting Persons are not obligated to take or refrain from taking any action with respect to any plans or proposals that the Reporting Persons may evaluate, discuss or determine to pursue. Accordingly, the Reporting Persons reserve the right to revise their plans or intentions at any time and to take any and all action that they may deem appropriate to maximize the value of their investment in the Issuer in light of their general investment policies, market conditions, subsequent developments regarding or affecting the Issuer and the general business and future prospects of the Issuer.

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
9 filings by this filer
8 other filings in the data moat
Short Interest · settle 2026-03-31
DTC 4.41
1,517,662 shares short · -2.8% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $916K
Point72 Asset Mgmt

Other 13D/G Filings on Allot Ltd.

FiledFormFilerStakeShares
2022-03-15 SC Outerbridge Capital Management LLC view →
2022-02-23 SC Outerbridge Capital Management LLC view →
2022-02-11 SC Outerbridge Capital Management LLC view →
2021-11-15 SC Outerbridge Capital Management LLC view →

Other Filings by QVT Financial LP

FiledFormIssuerStakeShares
2021-09-20 SC MP Materials Corp. / DE MP view →
2021-03-31 SC MP Materials Corp. / DE MP view →
2019-07-12 SC Urovant Sciences Ltd. view →
2019-07-12 SC Arbutus Biopharma Corp ABUS view →
2019-07-12 SC Axovant Gene Therapies Ltd. view →
2019-07-12 SC Myovant Sciences Ltd. view →
2019-03-19 SC Axovant Sciences Ltd. view →
2018-01-16 SC Arbutus Biopharma Corp ABUS view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →